The Need for a National AI Safety Intelligence Layer in Healthcare

Abstract

Artificial intelligence systems are rapidly becoming embedded in clinical workflows across the United States, influencing diagnostic reasoning, triage decisions, documentation, and treatment recommendations. Despite this accelerating adoption, the healthcare sector lacks a unified, independent, real time mechanism for monitoring the safety, reliability, and performance of AI tools in real world clinical environments. This absence constitutes a structural safety gap with significant implications for patient outcomes, clinician trust, regulatory oversight, and system level governance.

This white paper argues that the most effective and scalable solution is the establishment of a neutral AI safety intelligence layer, a national, independent infrastructure designed to collect, verify, analyse, and disseminate real world performance signals from clinicians and health systems. Drawing on historical precedents such as the Aviation Safety Reporting System, the paper demonstrates that human centred telemetry, when combined with rigorous de identification, independent governance, and systematic pattern detection, can dramatically improve safety outcomes in complex, high risk industries. The paper outlines the architectural, regulatory, and operational requirements for such a system, and references HealthAratus as an early operational implementation aligned with these principles.

1. Introduction

Artificial intelligence has entered a phase of accelerated integration into healthcare delivery. AI enabled clinical decision support systems, predictive analytics platforms, diagnostic imaging algorithms, and automated documentation tools are now deployed in hospitals, clinics, and telehealth environments across the United States. More than 1,000 AI and ML enabled medical devices have received clearance from the U.S. Food and Drug Administration, and hundreds of non regulated AI tools are embedded within electronic health record systems, operational platforms, and consumer facing health applications.¹

Despite this proliferation, the healthcare system lacks a unified mechanism to answer a foundational question: how do AI systems actually perform in real world clinical environments? This question is not trivial. AI systems behave differently in deployment than in controlled validation studies.² Model drift, workflow misalignment, data heterogeneity, clinician adaptation, and environmental variability all contribute to performance divergence.³ Yet the current regulatory and institutional frameworks do not provide real time visibility into these dynamics.

The absence of a national monitoring mechanism represents a critical safety gap. Without systematic intelligence on real world AI behaviour, health systems cannot reliably govern AI deployments, regulators cannot assess emerging risks, vendors cannot detect failures early, and clinicians cannot safely report anomalies. This gap is widening as AI systems become more autonomous, more integrated, and more influential in clinical decision making.

This white paper argues that the most effective solution is the creation of a neutral AI safety intelligence layer, a national, independent infrastructure modelled on the principles that made the Aviation Safety Reporting System one of the most successful safety systems in human history.⁴ Several organisations are exploring components of this model. HealthAratus is referenced throughout as an operational implementation aligned with the core requirements of neutrality, clinician powered telemetry, and real time signal verification.

2. Background: The Rise of AI in Healthcare

2.1 Expansion of AI Enabled Clinical Tools

AI adoption in healthcare has accelerated due to advances in machine learning, natural language processing, and multimodal foundation models.⁵ Clinical applications now include diagnostic imaging interpretation, risk prediction and stratification, automated triage, clinical documentation generation, treatment recommendation systems, operational optimisation tools, and patient engagement or symptom assessment. These tools are increasingly embedded within routine workflows, often operating behind the scenes within electronic health record systems or clinical platforms.⁶

2.2 Regulatory Landscape

The FDA has cleared more than 1,000 AI and ML enabled medical devices, many of which incorporate adaptive algorithms capable of changing behaviour over time.⁷ The FDA has acknowledged the need for continuous real world performance monitoring, particularly for adaptive AI systems.⁸ Current regulatory mechanisms, such as MAUDE adverse event reporting, are reactive, incomplete, and insufficient for capturing early signals of AI drift or workflow misalignment.⁹

The Office of the National Coordinator for Health Information Technology has introduced transparency requirements for predictive algorithms under the HTI 1 rule, but these requirements do not constitute a real time safety monitoring system.¹⁰ The National Institute of Standards and Technology has published the AI Risk Management Framework, emphasising the importance of continuous monitoring, human oversight, and systemic risk detection.¹¹ Implementation remains fragmented.

2.3 The Real World Performance Problem

AI systems validated in controlled environments often behave differently in real world settings.¹² Factors contributing to performance divergence include data distribution shifts, workflow variability, clinician adaptation, environmental noise, population heterogeneity, electronic health record integration differences, and vendor updates or model retraining. These factors can lead to model drift, hallucinations, unsafe recommendations, or subtle degradation in performance that may go unnoticed until patient harm occurs.¹³

3. The Healthcare AI Safety Gap

3.1 Lack of Real Time Visibility

Health systems currently rely on vendor provided performance dashboards, internal quality assurance processes, adverse event reporting, and periodic audits. These mechanisms are insufficient for detecting early signals of AI malfunction. Vendors cannot be the sole source of truth regarding their own tools, and health systems lack cross institutional visibility.¹⁴ This is the specific gap that Drift Watch and the Live Pulse feed are engineered to close.

3.2 Under Reporting of AI Related Issues

Clinicians frequently observe AI anomalies, including incorrect triage recommendations, hallucinated documentation, biased risk scores, and unsafe treatment suggestions.¹⁵ These observations are rarely reported due to fear of litigation, fear of professional discipline, fear of vendor retaliation, fear of hospital compliance action, lack of reporting mechanisms, and lack of clarity on responsibility. This structural pattern mirrors the early aviation industry, where pilots concealed mistakes due to fear of regulatory punishment.¹⁶

3.3 Fragmented Intelligence

Each stakeholder sees only a fragment of the AI ecosystem. Hospitals see local issues. Vendors see product specific issues. Regulators see adverse events. Clinicians see workflow level anomalies. No entity sees the full picture.¹⁷

3.4 Increasing Autonomy of AI Systems

AI systems are becoming more autonomous, generating clinical documentation, drafting orders, and influencing diagnostic reasoning.¹⁸ As autonomy increases, the consequences of undetected failures become more severe.

4. Lessons from Aviation: The ASRS Model

4.1 Historical Context

The Aviation Safety Reporting System, established in 1976, transformed aviation safety by shifting the industry from punitive enforcement to systemic learning.¹⁹ Before ASRS, pilots concealed mistakes due to fear of regulatory punishment, leading to repeated systemic failures.²⁰

4.2 Core Principles of ASRS

The system rests on four foundational principles.

Separation of church and state. NASA, not the FAA, manages safety reporting.²¹ Neutrality creates trust.

De identification and limited immunity. Reports are anonymised, and pilots receive limited immunity for inadvertent errors.²² This encourages reporting.

Human telemetry. Humans notice systemic flaws before machines do.²³ Human centred reporting reveals early signals.

Pattern detection. Thousands of reports reveal systemic design flaws before accidents occur.²⁴

4.3 Applicability to Healthcare AI

Healthcare AI shares structural similarities with aviation. Both operate in high risk environments with complex workflows and human machine interaction. Both experience rapid technological evolution. Both suffer under reporting driven by fear. Both require systemic intelligence. The ASRS model provides a proven blueprint for addressing these challenges.²⁵

5. The Case for a Neutral AI Safety Intelligence Layer

5.1 Definition

A neutral AI safety intelligence layer is an independent, national infrastructure designed to collect clinician generated signals, de identify and verify reports, detect systemic patterns, monitor real world AI performance, and provide evidence based intelligence to stakeholders. This system is not a regulator, vendor, or health system. Neutrality is essential for trust.

5.2 Core Functions

The intelligence layer performs five critical functions.

Clinician powered telemetry. Clinicians submit observations of AI behaviour, including drift, hallucinations, unsafe recommendations, workflow misalignment, bias patterns, and integration failures. The mechanism through which this happens on HealthAratus is the Signal Booth.

Signal verification. Reports are cross checked across multiple clinicians, institutions, and vendors. This produces verified intelligence rather than anecdotal reports.

Evidence aggregation. Signals are aggregated to detect systemic risks, cross vendor patterns, workflow specific issues, and population specific failures.

Performance scoring. AI tools receive evidence based performance scores reflecting safety, stability, drift, clinician sentiment, and workflow alignment. The HealthAratus Score is an early example of a public, transparent implementation of this principle.

Intelligence dissemination. Insights are shared with health systems, vendors, regulators, and researchers to enable proactive risk mitigation.

6. Why Neutrality Is Essential

6.1 Avoiding Conflicts of Interest

Vendors cannot objectively monitor their own tools. Hospitals cannot monitor tools deployed elsewhere. Regulators cannot monitor tools in real time. Neutrality eliminates conflicts of interest.

6.2 Building Clinician Trust

Clinicians will not report AI anomalies if reports go to their employer, if reports go to the vendor, or if reports trigger punitive action. Neutrality creates psychological safety.¹⁶

6.3 Ensuring Systemic Visibility

Only a neutral entity can aggregate signals across institutions, vendors, geographies, and populations. This cross system visibility is essential for detecting systemic risks.

The risk in agentic clinical AI lives in the network, not the node. No hospital and no vendor can see the network alone.

7. Architectural Requirements for a Neutral AI Safety Intelligence Layer

The establishment of a national neutral AI safety intelligence layer requires a robust, multi component architecture capable of collecting, processing, verifying, and disseminating real world performance signals from diverse clinical environments. The architecture must ensure neutrality, protect clinician identity, maintain data integrity, and support scalable national deployment.

7.1 Core Architectural Principles

Four principles are non negotiable: neutrality, de identification, verification, and scalability. These principles mirror the architectural foundations of the ASRS, which has demonstrated sustained effectiveness for nearly five decades.⁴

7.2 System Components

The layer consists of five primary components: the clinician signal intake layer, the de identification engine, the signal verification pipeline, the evidence aggregation layer, and the intelligence dissemination layer.

The intake layer must be accessible, intuitive, and designed to minimise friction. Research in human machine interaction demonstrates that ease of reporting significantly increases participation rates in safety systems.² The de identification engine removes clinician identifiers, patient identifiers, institutional identifiers, temporal markers, geospatial metadata, and device specific identifiers. Advanced natural language processing techniques are required to ensure robust de identification, particularly for free text submissions.³

The verification pipeline applies cross clinician corroboration, cross institutional pattern matching, cross vendor comparison, statistical anomaly detection, and temporal trend analysis. The aggregation layer synthesises verified signals into structured intelligence. The dissemination layer delivers reports to health systems, dashboards for vendors, alerts for regulators, and data for researchers, together with public safety summaries. HealthAratus operates a working implementation of this five layer architecture through the Intelligence Engine and the How HealthAratus Works platform overview.

8. Human Centred Telemetry in Healthcare AI

Human centred telemetry is the systematic collection of human observations about machine behaviour. In healthcare, clinicians are uniquely positioned to detect early signals of AI malfunction due to their proximity to patient care and their ability to interpret contextual nuance that automated monitoring systems miss.

AI systems often fail in subtle, context dependent ways: slight shifts in triage recommendations, documentation hallucinations that appear plausible, risk scores that diverge from clinical intuition, workflow misalignments that slow care delivery, or bias patterns affecting specific populations. Clinicians notice these anomalies because they interact with AI systems within the full complexity of clinical environments.⁴

Human telemetry has proven essential in aviation, nuclear energy, and industrial manufacturing. In aviation, ASRS reports have repeatedly identified systemic design flaws before accidents occurred.⁵ In nuclear energy, operator reported anomalies have prevented catastrophic failures.⁶ These industries demonstrate that human centred reporting is indispensable for detecting early signals of systemic risk. In healthcare, clinician powered telemetry enables detection of model drift, unsafe recommendations, workflow incompatibilities, integration failures, population specific performance issues, and vendor update related anomalies. These signals often emerge before measurable adverse events occur.

9. De Identification Protocols

De identification is essential for protecting clinician identity and ensuring psychological safety. Without robust de identification, clinicians may fear retaliation, litigation, or professional discipline, leading to under reporting.

Effective de identification must remove names, titles, institutional affiliations, dates and times, patient identifiers, device identifiers, location metadata, and workflow context clues. Natural language processing based de identification systems must be trained on diverse clinical language to ensure accuracy.⁷ Inadequate de identification leads to clinician identification, institutional identification, legal exposure, loss of trust, and reduced participation. NIST and ONC have begun developing standards for de identification in AI systems, emphasising contextual de identification, multi modal de identification, risk based approaches, and continuous monitoring. HealthAratus operates a de identification engine aligned with these emerging standards.

10. Verification Pipelines and Statistical Signal Detection

Verification transforms raw clinician observations into reliable intelligence. Without verification, the system risks false positives, noise, and misinterpretation. Verification pipelines must include cross clinician corroboration, cross institutional comparison, cross vendor analysis, temporal trend detection, and statistical anomaly detection. Statistical techniques include Bayesian inference, time series analysis, drift detection algorithms, outlier detection, clustering, and regression analysis. These techniques enable detection of subtle performance shifts before they escalate into adverse events.

11. Early Warning Systems

Early warning systems provide proactive alerts to stakeholders when AI systems exhibit signs of malfunction. Signals include drift indicators, sudden performance degradation, workflow misalignment patterns, population specific anomalies, and vendor update related issues. Alerts must be disseminated to health systems, vendors, regulators, and researchers. Timely dissemination enables rapid mitigation. The public Top Movers feed and the Drift Watch module on HealthAratus are examples of early warning outputs designed for this purpose.

12. Governance Models for a National AI Safety Intelligence Layer

The governance structure of a neutral AI safety intelligence layer is foundational to its legitimacy, effectiveness, and long term sustainability. Governance determines how the system is operated, how data is managed, how stakeholders participate, and how trust is maintained across the healthcare ecosystem.

12.1 Principles of Effective Governance

Neutrality, transparency, accountability, inclusivity, and resilience must all be met. These principles mirror those used in the governance of the ASRS, which has maintained trust and effectiveness for nearly five decades.¹

12.2 Governance Models Considered

Three models are viable. An independent public private consortium resembles the governance structure of chaordic organisations such as VISA, balancing competition and cooperation. A federated national network distributes governance across regional nodes, similar to public health surveillance networks. A government mandated independent entity resembles the ASRS, where NASA manages reporting independently from the FAA.

12.3 Recommended Hybrid Model

The recommended model combines independent nonprofit governance, government charter or endorsement, public private funding, and multi stakeholder oversight. This balance secures neutrality, sustainability, and national legitimacy simultaneously. This is the model HealthAratus operates against today, described in detail in the flagship Chaordic Imperative essay.

13. Regulatory Alignment and Integration

A national AI safety intelligence layer must align with existing regulatory frameworks while providing capabilities that regulators currently lack.

FDA alignment. The FDA regulates AI and ML enabled medical devices through 510(k) clearance, de novo classification, and PMA approval, with emerging real world performance monitoring requirements. However, FDA monitoring is currently limited to reactive adverse event reporting through MAUDE.³ A neutral intelligence layer provides real time signals, drift detection, cross institutional patterns, early warning alerts, and evidence for regulatory review.

ONC alignment. ONC HTI 1 requires transparency for predictive algorithms used in certified EHR systems.⁴ HTI 1 does not mandate real time safety monitoring. The intelligence layer provides clinician generated safety signals, workflow specific performance data, integration failure detection, and bias pattern identification that operationalise ONC transparency goals.

NIST alignment. The NIST AI Risk Management Framework emphasises continuous monitoring, human oversight, systemic risk detection, and contextual evaluation. The intelligence layer operationalises these principles at national scale.⁵

CMS alignment. CMS quality programs increasingly incorporate digital health tools. AI safety influences reimbursement, quality metrics, and value based care models. The intelligence layer provides the evidence needed for CMS policy development.

14. Ethical Considerations

Ethical considerations are central to the design and operation of a national AI safety intelligence layer. Clinicians must be protected from retaliation, litigation, professional discipline, vendor pressure, and institutional consequences. Robust de identification is essential.⁶ Although clinician reports focus on AI behaviour, patient data may be inadvertently included, so HIPAA compliance, GDPR alignment, contextual de identification, and multi modal privacy protection are all required.

Bias can emerge in signal intake, verification, aggregation, scoring, or dissemination. Ethical governance requires bias audits, diverse clinician participation, transparent scoring criteria, and independent oversight. AI systems may perform differently across racial, ethnic, socioeconomic, geographic, and clinical specialty groups. A neutral intelligence layer must detect and report population specific performance issues to support equitable care.⁷

Performance scores must be used ethically. Not for punitive action. Not for vendor exclusion without evidence. Not for clinician evaluation. Not for institutional ranking. Scores exist to support safety, not to enable punishment.

15. Comparative Analysis: ASRS vs. Healthcare AI Safety Intelligence Layer

The ASRS provides a proven model for safety reporting in complex, high risk environments. Both systems require neutral governance, de identification, human centred telemetry, pattern detection, early warning alerts, and multi stakeholder participation. These similarities demonstrate the applicability of the ASRS model to healthcare AI.

The differences require enhanced verification and aggregation capabilities. AI systems evolve faster than aircraft systems. AI failures are often subtle and context dependent. AI systems are embedded in diverse workflows. AI updates occur frequently and automatically. AI performance varies across populations. ASRS demonstrates that neutrality is essential, human reporting is indispensable, de identification increases participation, pattern detection prevents accidents, and non punitive systems improve safety. These lessons directly inform the design of a healthcare AI safety intelligence layer.

16. Implementation Pathways

Implementation proceeds in four phases. Pilot programs launch in large academic medical centres, regional health systems, and diverse clinical environments to test signal intake, validate de identification, refine verification pipelines, and assess clinician participation. Regional networks then support cross institutional signal aggregation, regional pattern detection, and local governance participation. National integration follows, requiring federal endorsement, multi stakeholder governance, public private funding, and standardised protocols. Finally, regulators integrate the intelligence into oversight, use signals for policy development, and support national adoption. HealthAratus has completed early stage pilots aligned with Phase 1.

17. Performance Scoring Frameworks for Healthcare AI Systems

A national intelligence layer must incorporate a rigorous, evidence based performance scoring framework capable of evaluating AI systems across diverse clinical environments. Scoring serves safety assessment, reliability evaluation, comparative analysis, procurement support, regulatory insight, and vendor improvement.

A comprehensive score must incorporate safety signals, evidence depth, deployment stability, clinician sentiment, drift indicators, and bias patterns. Methodological requirements include multi modal data integration, cross institutional normalisation, temporal weighting, bias mitigation, and full public transparency of methodology. HealthAratus publishes its scoring methodology in full at the HealthAratus Methodology page, and the composite output is available at the HealthAratus Score.

18. National Safety Metrics for Healthcare AI

A national layer must establish standardised safety metrics to support consistent evaluation across the healthcare ecosystem. Categories include performance metrics (accuracy, sensitivity, specificity, positive and negative predictive value), stability metrics (drift frequency, drift magnitude, update impact), workflow metrics (integration success rate, workflow alignment score, clinician override frequency), bias metrics (population specific performance, disparity ratios, equity indicators), and safety event metrics (near miss frequency, adverse event correlation, early warning signals). Standardisation ensures comparability across vendors, consistency across institutions, reliability across populations, transparency for regulators, and trust for clinicians. Standardised metrics must align with FDA real world performance requirements, ONC HTI 1 transparency rules, the NIST AI RMF, and CMS quality programs.

19. Cross Vendor Comparative Analysis

A neutral layer enables cross vendor comparison across safety performance, drift frequency, bias patterns, workflow alignment, update stability, and clinician sentiment. Comparative analysis supports evidence based procurement, vendor improvement, regulatory insight, and systemic risk detection. Vendor resistance, proprietary data, integration variability, and population heterogeneity are real challenges. Neutral governance mitigates them. The public HealthAratus Rankings demonstrate cross vendor comparison at national scale.

20. Population Specific AI Performance

AI systems often perform differently across populations due to data distribution differences, socioeconomic factors, geographic variation, clinical practice variation, and demographic diversity. Population specific analysis is essential for equity, safety, regulatory compliance, and clinical trust. Signal types include racial bias, ethnic bias, gender bias, age related performance differences, socioeconomic disparities, and geographic variation. The intelligence layer detects population specific anomalies through cross institutional aggregation, statistical drift analysis, and clinician powered telemetry. The most widely cited empirical example remains Obermeyer et al., who demonstrated large scale racial bias in a widely used population health algorithm.¹⁰

21. Case Studies

21.1 Drift in Diagnostic Imaging AI

A diagnostic imaging AI system exhibited subtle drift over six months, leading to decreased sensitivity for early stage lung nodules. Clinicians reported anomalies through the intelligence layer, enabling early detection and vendor remediation. This class of failure is only visible when signals aggregate across institutions, which is precisely what the Signal Network is engineered to do.

21.2 Workflow Misalignment in Triage AI

A triage AI system recommended inappropriate escalation for low risk patients. Clinician reports revealed workflow misalignment, prompting integration adjustments. The Epic Sepsis Model case is the archetype: a JAMA Internal Medicine study found the model missed a majority of sepsis cases and generated excessive false alerts across multiple hospitals simultaneously. No single hospital detected the scale of the failure in isolation.

21.3 Population Specific Bias in Risk Prediction AI

A risk prediction AI system under predicted risk for Black patients. Cross institutional analysis identified the bias pattern, leading to model retraining.¹⁰ These case studies illustrate why cross institutional aggregation is a load bearing property of the intelligence layer.

22. National Deployment Strategy for a Neutral AI Safety Intelligence Layer

Deploying a national neutral AI safety intelligence layer requires a phased, coordinated strategy that integrates technical infrastructure, governance, regulatory alignment, stakeholder engagement, and sustainable funding.

Phase 1: foundational infrastructure development. Signal intake systems, de identification engines, verification pipelines, evidence aggregation layers, and intelligence dissemination platforms are built to support millions of annual signals. Governance is established before deployment. Early coordination with FDA, ONC, CMS, and NIST ensures alignment with emerging AI safety regulations. Pilot sites include academic medical centres, community hospitals, rural clinics, telehealth networks, and diverse geographic regions.

Phase 2: pilot implementation and evaluation. Clinician participation is essential. Engagement strategies include clear communication of de identification protocols, assurance of non punitive reporting, integration into existing workflows, training modules, and feedback loops. Research shows that clinician trust increases when reporting systems are neutral and non punitive.¹

Phase 3: regional network expansion. Regional hubs provide local governance participation, regional pattern detection, population specific analysis, and workflow specific insights. Regional data normalisation ensures comparability across institutions, populations, workflows, and geographies.

Phase 4: national integration. Federal endorsement provides legitimacy, sustainability, regulatory alignment, and national visibility. A national governance board includes clinicians, patients, vendors, regulators, researchers, and ethicists. National data standards define signal formats, de identification protocols, verification criteria, scoring methodologies, and dissemination practices.

23. Funding Models for Long Term Sustainability

A public private funding model is recommended, combining federal funding, health system contributions, vendor participation fees, philanthropic support, and research grants. Federal funding secures infrastructure, governance operations, national dissemination, and regulatory alignment. Health systems contribute based on size, AI deployment volume, and risk exposure. Vendors contribute fees for performance reports, drift alerts, bias detection insights, and integration support. Philanthropic funding supports equity initiatives and population specific analysis. Grants support methodological innovation.

24. Stakeholder Roles and Responsibilities

Clinicians provide human centred telemetry, workflow insights, safety observations, and bias detection signals through mechanisms such as the HealthAratus Signal Booth. Health systems provide deployment data, workflow metadata, integration insights, and institutional participation, and consume intelligence through the Governance Console. Vendors provide model update logs, integration data, and performance metadata, and collaborate on remediation via Vendor Transparency. Regulators use intelligence for policy development, oversight, risk assessment, and safety alerts. Researchers use intelligence for bias analysis, drift detection research, workflow studies, and safety science. Patients benefit from safer AI systems, more equitable care, and transparent performance data.

25. Long Term Sustainability Considerations

Sustainability requires continuous innovation in methodologies, verification pipelines, de identification, bias detection, and integration of new modalities. Workforce development requires training programs, safety science education, AI literacy initiatives, and clinician engagement strategies. Regulations must evolve to incorporate real time monitoring, drift detection, bias reporting, and performance scoring. Ethical stewardship requires independent oversight, transparent operations, equity initiatives, and privacy protection. National resilience requires redundant infrastructure, disaster recovery plans, cybersecurity protocols, and governance continuity.

26. Integration with Clinical Workflows

Integration is essential for clinician participation and signal reliability. Reporting must be fast, intuitive, non disruptive, and integrated into existing systems. EHR integration supports contextual reporting, workflow metadata capture, and seamless clinician participation. Clinicians must be able to report via text, voice, video, and structured forms. Feedback loops support clinician trust, system improvement, and transparency.

27. National Impact Analysis

27.1 Clinical Impact

Early detection of drift, hallucinations, and unsafe recommendations reduces the likelihood of AI related harm.¹ Cross institutional intelligence supports model refinement, reducing diagnostic errors associated with AI systems.² Detection of workflow misalignment enables vendors and health systems to optimise integration, reducing clinician burden.³ Neutral governance and de identification increase clinician willingness to engage with AI systems and report anomalies.⁴

27.2 Operational Impact

Health systems gain access to independent performance scores, enabling informed procurement and reducing reliance on vendor claims. Early warning systems reduce operational disruptions caused by AI failures. Vendors receive verified intelligence on real world performance, enabling targeted remediation. Cross institutional intelligence reveals integration challenges across EHRs and clinical platforms, supporting interoperability improvements.

27.3 Regulatory Impact

Regulators gain access to real time performance signals, enabling proactive oversight rather than reactive response. Aggregated intelligence informs regulatory frameworks for adaptive AI systems, drift monitoring, and bias detection. The layer provides evidence needed for emerging FDA requirements for continuous monitoring of AI and ML enabled medical devices.⁵ It operationalises NIST principles of continuous monitoring, human oversight, and systemic risk detection.⁶

27.4 Societal Impact

Patients benefit from safer AI systems and reduced risk of AI related harm. Detection of population specific bias supports equitable care across racial, ethnic, socioeconomic, and geographic groups. Public safety summaries increase transparency and trust in healthcare AI systems. A national layer strengthens national resilience against systemic AI failures.

28. Future Directions

Future systems will incorporate multimodal drift detection, real time statistical monitoring, adaptive thresholding, and context aware drift analysis. Integration of voice, video, text, workflow metadata, and sensor data will enhance signal richness. AI systems will assist in signal classification, pattern detection, bias identification, and temporal trend analysis. Foundation models will support enhanced de identification, semantic signal clustering, and predictive safety alerts. Methodological advancements include intersectional bias analysis, expanded scoring frameworks, and Bayesian ensemble verification pipelines. Global collaboration will support cross country intelligence sharing, international safety standards, and harmonised regulatory frameworks. The European Union AI Act and the United Kingdom AI safety initiatives provide opportunities for international alignment.⁷

29. Policy Recommendations

Federal endorsement is essential for legitimacy, sustainability, regulatory alignment, and national visibility. National standards should define signal formats, de identification protocols, verification criteria, scoring methodologies, and dissemination practices. Incentives for clinician participation include non punitive reporting, de identification guarantees, workflow aligned reporting tools, and feedback loops. Vendors should be required to provide update logs, support integration, collaborate on remediation, and participate in scoring frameworks. Regulators should integrate intelligence into oversight, use signals for policy development, and support national adoption.

30. Limitations

Clinician reporting may be influenced by workload, perceived risk, and institutional culture. Data quality varies across institutions, workflows, and populations. Some vendors may resist participation due to competitive concerns, proprietary data, or liability fears. National deployment requires funding, infrastructure, and workforce development. Ethical challenges include privacy protection, bias mitigation, transparency, and governance accountability. Each of these limitations is mitigable, but none can be ignored.

31. Conclusion

Artificial intelligence is transforming healthcare, but the absence of a national mechanism for monitoring real world AI performance represents a critical safety gap. A neutral AI safety intelligence layer, modelled on the principles of the Aviation Safety Reporting System, provides the most effective, scalable, and trusted solution for closing this gap.

By integrating clinician powered telemetry, rigorous de identification, multi layer verification, evidence aggregation, and performance scoring, the intelligence layer enables early detection of drift, bias, workflow misalignment, and unsafe recommendations. It supports evidence based procurement, regulatory oversight, vendor accountability, and equitable care.

Emerging implementations such as HealthAratus demonstrate the feasibility and value of this model. National adoption will require coordinated action across stakeholders, sustainable funding, regulatory alignment, and ethical stewardship. The establishment of a national neutral AI safety intelligence layer is not merely beneficial. It is essential for ensuring the safety, reliability, and equity of AI enabled healthcare in the United States.

The safety of United States clinical AI will not be determined by the sophistication of any single model. It will be determined by whether the country builds an intelligence layer capable of seeing every model at once.

32. References

References follow AMA citation style. All external links resolve to the authoritative publisher.

1. U.S. Food and Drug Administration. Artificial Intelligence and Machine Learning (AI/ML) Enabled Medical Devices. FDA; 2024. fda.gov
2. Sendak MP, D’Arcy J, Kashyap S, Gao M, Nichols M. A path for translation of machine learning products into healthcare delivery. NPJ Digit Med. 2020;3(1):1–5. nature.com
3. Finlayson SG, Subbaswamy A, Singh K, et al. The clinician and dataset shift in artificial intelligence. N Engl J Med. 2021;385(3):283–286. nejm.org
4. NASA. Aviation Safety Reporting System (ASRS). NASA Ames Research Center; 2023. asrs.arc.nasa.gov
5. U.S. Food and Drug Administration. Proposed Regulatory Framework for Modifications to Artificial Intelligence/Machine Learning (AI/ML) Based Software as a Medical Device (SaMD). FDA; 2023. fda.gov
6. National Institute of Standards and Technology. AI Risk Management Framework (AI RMF 1.0). NIST; 2023. nist.gov
7. European Commission. The EU Artificial Intelligence Act. European Union; 2024. artificialintelligenceact.eu
8. Office of the National Coordinator for Health Information Technology. Health Data, Technology, and Interoperability (HTI 1) Final Rule. ONC; 2024. healthit.gov
9. Amann J, Blasimme A, Vayena E, Frey D, Madai VI. Explainability for artificial intelligence in healthcare: a multidisciplinary perspective. BMC Med Inform Decis Mak. 2020;20(1):310. pubmed
10. Obermeyer Z, Powers B, Vogeli C, Mullainathan S. Dissecting racial bias in an algorithm used to manage the health of populations. Science. 2019;366(6464):447–453. pubmed
11. Topol EJ. High performance medicine: the convergence of human and artificial intelligence. Nat Med. 2019;25(1):44–56. nature.com
12. Wiens J, Saria S, Sendak M, et al. Do no harm: a roadmap for responsible machine learning for health care. Nat Med. 2019;25(9):1337–1340. nature.com
13. Wong A, Otles E, Donnelly JP, et al. External validation of a widely implemented proprietary sepsis prediction model in hospitalized patients. JAMA Intern Med. 2021;181(8):1065–1070. jamanetwork.com
14. National Academy of Medicine. Artificial Intelligence in Health Care: Hope Not Hype, Promise Not Peril. NAM; 2022. nam.edu

Related HealthAratus Reading

• The HealthAratus White Paper
• The Chaordic Imperative
• Clinician Telemetry as the Foundation of Real World AI Safety
• The Hidden Failure Modes of Clinical AI
• The Accountability Vacuum in Clinical AI
• How HealthAratus Works and the HealthAratus Methodology